SURO CAPITAL CORP.
SSSSAnalytical Summary
On an absolute basis, SURO CAPITAL CORP. shows weak fundamentals, weighed down by FCF / Net Income. These readings use fixed quality thresholds rather than peer benchmarks, because too few comparable companies are available to rank against.
19-Year Financial Trajectory
Quarterlyinfo Signals below are graded against fixed quality thresholds, not peers — peer ranking needs more comparable companies.
Bullish Indicators
- No bullish signals detected.
Bearish Risks
- FCF / Net IncomeFCF / Net Income of 0.70x is caution on an absolute basis (target > 1x)
Health Breakdown
Statement lens
Choose the reporting cadence, isolate a period range, or search directly for a metric.
| Metric | Q1 FY2026 Mar 31, 2026 10-Q ↗ | Q4 FY2025 Dec 31, 2025 10-K ↗ | Q3 FY2025 Sep 30, 2025 10-Q ↗ | Q2 FY2025 Jun 30, 2025 10-Q ↗ | Q1 FY2025 Mar 31, 2025 10-Q ↗ | Q4 FY2024 Dec 31, 2024 10-K ↗ | Q3 FY2024 Sep 30, 2024 10-Q ↗ | Q2 FY2024 Jun 30, 2024 10-Q ↗ | Q1 FY2024 Mar 31, 2024 10-Q ↗ | Q4 FY2023 Dec 31, 2023 10-K ↗ | Q3 FY2023 Sep 30, 2023 10-Q ↗ | Q2 FY2023 Jun 30, 2023 10-Q ↗ | Q1 FY2023 Mar 31, 2023 10-Q ↗ | Q4 FY2022 Dec 31, 2022 10-K ↗ | Q3 FY2022 Sep 30, 2022 10-Q ↗ | Q2 FY2022 Jun 30, 2022 10-Q ↗ | Q1 FY2022 Mar 31, 2022 10-Q ↗ | Q4 FY2021 Dec 31, 2021 10-K ↗ | Q3 FY2021 Sep 30, 2021 10-Q ↗ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Growth YoY (%) | N/M |
-8700.0%
Weak
Weak
Year-over-year change in earnings per share
Optimal:
> 10%
|
N/M | N/M |
96.6%
Excellent
↑
Excellent
Improving
Year-over-year change in earnings per share
Optimal:
> 10%
|
97.1%
Excellent
Excellent
Year-over-year change in earnings per share
Optimal:
> 10%
|
N/M |
25.0%
Good
Good
Year-over-year change in earnings per share
Optimal:
> 10%
|
N/M |
29.2%
Excellent
↑
Excellent
Improving
Year-over-year change in earnings per share
Optimal:
> 10%
|
N/M |
80.5%
Excellent
↑
Excellent
Improving
Year-over-year change in earnings per share
Optimal:
> 10%
|
-75.8%
Weak
Weak
Year-over-year change in earnings per share
Optimal:
> 10%
|
31.4%
Excellent
Excellent
Year-over-year change in earnings per share
Optimal:
> 10%
|
N/M | — | — | — | — |
| Net Income Growth YoY (%) | N/M | N/M |
96.3%
Excellent
→
Excellent
Stable
Year-over-year change in net income |
96.3%
Excellent
Excellent
Year-over-year change in net income |
96.3%
Excellent
Excellent
Year-over-year change in net income |
N/M | N/M | N/M | N/M |
26.4%
Excellent
↑
Excellent
Improving
Year-over-year change in net income |
— |
-77.4%
Weak
Weak
Year-over-year change in net income |
-77.4%
Weak
Weak
Year-over-year change in net income |
— | — | — | — | — | — |
| FCF Growth YoY (%) |
-43.8%
Weak
↓
Weak
Declining
Year-over-year change in free cash flow |
— |
99.5%
Excellent
Excellent
Year-over-year change in free cash flow |
156.7%
Excellent
Excellent
Year-over-year change in free cash flow |
N/M | — | N/M | — |
213.6%
Excellent
Excellent
Year-over-year change in free cash flow |
— | — | — | N/M | — | — | — | — | — | — |
| EPS CAGR 3Y (%) |
237.1%
Excellent
Excellent
Compound annual EPS growth over 3 years |
— | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Metric | Q1 FY2026 Mar 31, 2026 10-Q ↗ | Q4 FY2025 Dec 31, 2025 10-K ↗ | Q3 FY2025 Sep 30, 2025 10-Q ↗ | Q2 FY2025 Jun 30, 2025 10-Q ↗ | Q1 FY2025 Mar 31, 2025 10-Q ↗ | Q4 FY2024 Dec 31, 2024 10-K ↗ | Q3 FY2024 Sep 30, 2024 10-Q ↗ | Q2 FY2024 Jun 30, 2024 10-Q ↗ | Q1 FY2024 Mar 31, 2024 10-Q ↗ | Q4 FY2023 Dec 31, 2023 10-K ↗ | Q3 FY2023 Sep 30, 2023 10-Q ↗ | Q2 FY2023 Jun 30, 2023 10-Q ↗ | Q1 FY2023 Mar 31, 2023 10-Q ↗ | Q4 FY2022 Dec 31, 2022 10-K ↗ | Q3 FY2022 Sep 30, 2022 10-Q ↗ | Q2 FY2022 Jun 30, 2022 10-Q ↗ | Q1 FY2022 Mar 31, 2022 10-Q ↗ | Q4 FY2021 Dec 31, 2021 10-K ↗ | Q3 FY2021 Sep 30, 2021 10-Q ↗ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FCF / Net Income (x) |
-0.04x
Weak
↑
Weak
Improving
Free cash flow relative to reported net income
Optimal:
> 1x
|
-0.22x
Weak
↑
Weak
Improving
Free cash flow relative to reported net income
Optimal:
> 1x
|
0.12x
Weak
↑
Weak
Improving
Free cash flow relative to reported net income
Optimal:
> 1x
|
-41.82x
Weak
↑
Weak
Improving
Free cash flow relative to reported net income
Optimal:
> 1x
|
4.61x
Excellent
↑
Excellent
Improving
Free cash flow relative to reported net income
Optimal:
> 1x
|
-279.54x
Weak
↓
Weak
Declining
Free cash flow relative to reported net income
Optimal:
> 1x
|
0.95x
Caution
↓
Caution
Declining
Free cash flow relative to reported net income
Optimal:
> 1x
|
-0.59x
Weak
↓
Weak
Declining
Free cash flow relative to reported net income
Optimal:
> 1x
|
-1.03x
Weak
↓
Weak
Declining
Free cash flow relative to reported net income
Optimal:
> 1x
|
4.96x
Excellent
↓
Excellent
Declining
Free cash flow relative to reported net income
Optimal:
> 1x
|
10.75x
Excellent
↑
Excellent
Improving
Free cash flow relative to reported net income
Optimal:
> 1x
|
— |
1.76x
Excellent
↑
Excellent
Improving
Free cash flow relative to reported net income
Optimal:
> 1x
|
-0.04x
Weak
↑
Weak
Improving
Free cash flow relative to reported net income
Optimal:
> 1x
|
— |
-0.47x
Weak
Weak
Free cash flow relative to reported net income
Optimal:
> 1x
|
-0.07x
Weak
Weak
Free cash flow relative to reported net income
Optimal:
> 1x
|
— | — |
| Metric | Q1 FY2026 Mar 31, 2026 10-Q ↗ | Q4 FY2025 Dec 31, 2025 10-K ↗ | Q3 FY2025 Sep 30, 2025 10-Q ↗ | Q2 FY2025 Jun 30, 2025 10-Q ↗ | Q1 FY2025 Mar 31, 2025 10-Q ↗ | Q4 FY2024 Dec 31, 2024 10-K ↗ | Q3 FY2024 Sep 30, 2024 10-Q ↗ | Q2 FY2024 Jun 30, 2024 10-Q ↗ | Q1 FY2024 Mar 31, 2024 10-Q ↗ | Q4 FY2023 Dec 31, 2023 10-K ↗ | Q3 FY2023 Sep 30, 2023 10-Q ↗ | Q2 FY2023 Jun 30, 2023 10-Q ↗ | Q1 FY2023 Mar 31, 2023 10-Q ↗ | Q4 FY2022 Dec 31, 2022 10-K ↗ | Q3 FY2022 Sep 30, 2022 10-Q ↗ | Q2 FY2022 Jun 30, 2022 10-Q ↗ | Q1 FY2022 Mar 31, 2022 10-Q ↗ | Q4 FY2021 Dec 31, 2021 10-K ↗ | Q3 FY2021 Sep 30, 2021 10-Q ↗ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income, GAAP (USD) | $155.64M | $-20.13M | $-806.72K | $-806.72K | $-806.72K | $44.53K | $-22.07M | $-22.07M | $-22.07M | $-9.12M | $4.62M | $4.62M | $4.62M | $-12.39M | — | $20.46M | $20.46M | — | — |
| Operating Cash Flow (USD) | $-5.76M | $4.40M | $-100.71K | $33.74M | $-3.72M | $-12.45M | $-20.89M | $12.97M | $22.74M | $-45.29M | $49.64M | — | $8.10M | $518.75K | — | $-9.56M | $-1.39M | $45.90M | — |
Secondary lens
Benchmark Lens
Benchmarks are disabled until comparison data is defensible.
Unavailable
Benchmark Lens
Benchmarks are disabled until comparison data is defensible.
Benchmarks unavailable
Verdicts use absolute quality thresholds, not peer comparison — only 0 comparable companies are currently available for ranking.
Use Statement Evidence firstCompare SSSS with peers
Stack SSSS against similar companies across every metric on this page.
north_east Open comparisonbar_chart Data from SEC EDGAR XBRL filings
Synced 1 week ago 6 years · 19 quarters